Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Regulatory SupportKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Regulatory Support
West Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.
Regulatory Support
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
- Home
Blog
The West Blog
Latest Post
December 28, 2020
Particles in Injectable Drugs
A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
Categories
Search the Blog
Archive
Load more
Loading...
Previous Posts

December 23, 2020
Container Closure Integrity Evaluation for Cell and Gene Therapies

Olga Laskina, PhD.
Sr. Technical Account Specialist, TCS NA

September 11, 2020
Introducing West’s New Interactive Integrated Solutions Webpage

Shari Krusniak
Director, Marketing, Contract Manufacturing & Integrated Solutions

August 14, 2020
How the FDA PFDD initiative is bringing the patients voice earlier into drug development

Victoria Morgan
Global Director, Segment Marketing

May 15, 2020
Speed to Market with a Platform Approach

Fran DeGrazio
Chief Scientific Officer, Scientific Affairs
Load more
Loading...